What Sal looks for when investing
Capable and committed academic founders
Strong biotech patents
Interest from Strategics
Capital efficiency
Multiple uses
Portfolio
What makes Sal a successful early stage biotech investor
An engaged network of Boston’s angels and decades of experience investing in life science companies in the early stage.
